Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells
Authors
Keywords
Pancreatic cancer, Gemcitabine resistance, RNA-seq, Differential genes and microRNAs, MicroRNA-mRNA network
Journal
TUMOR BIOLOGY
Volume 36, Issue 6, Pages 4525-4534
Publisher
Springer Nature
Online
2015-02-26
DOI
10.1007/s13277-015-3097-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer
- (2014) Anupama Mittal et al. BIOMATERIALS
- MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G1/S transition and apoptosis by targeting p21WAF1/CIP1
- (2014) H Wang et al. BRITISH JOURNAL OF CANCER
- VASP Activation via the Gα13/RhoA/PKA Pathway Mediates Cucurbitacin-B-Induced Actin Aggregation and Cofilin-Actin Rod Formation
- (2014) Yan-Ting Zhang et al. PLoS One
- Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer
- (2014) Allen S. Ho et al. Translational Oncology
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Function of miRNA in Controlling Drug Resistance of Human Cancers
- (2013) Liu Hong et al. CURRENT DRUG TARGETS
- Comprehensive analysis of the functional microRNA–mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression
- (2013) Yongsheng Li et al. NUCLEIC ACIDS RESEARCH
- Paclitaxel Resistance and Multicellular Spheroid Formation Are Induced by Kallikrein-Related Peptidase 4 in Serous Ovarian Cancer Cells in an Ascites Mimicking Microenvironment
- (2013) Ying Dong et al. PLoS One
- Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots
- (2012) Kwan Hyi Lee et al. Nanomedicine-Nanotechnology Biology and Medicine
- miRNA-Mediated Gene Silencing by Translational Repression Followed by mRNA Deadenylation and Decay
- (2012) S. Djuranovic et al. SCIENCE
- MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer
- (2011) Kenoki Ohuchida et al. ANNALS OF SURGICAL ONCOLOGY
- High Mobility Group Box 1 (HMGB1) Activates an Autophagic Response to Oxidative Stress
- (2011) Daolin Tang et al. ANTIOXIDANTS & REDOX SIGNALING
- The non-receptor tyrosine kinase c-Src mediates the PDGF-induced association between Furin and pro-MT1-MMP in HPAC pancreatic cells
- (2011) Chong Shi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MicroRNA and drug resistance
- (2010) J Ma et al. CANCER GENE THERAPY
- MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
- (2010) Elisa Giovannetti et al. CANCER RESEARCH
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
- (2009) Y. Li et al. CANCER RESEARCH
- MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy
- (2009) Todd Boren et al. GYNECOLOGIC ONCOLOGY
- Overlapping expression of microRNAs in human embryonic colon and colorectal cancer
- (2008) Mariano Monzo et al. CELL RESEARCH
- Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
- (2008) M. P. Kim et al. CLINICAL CANCER RESEARCH
- miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
- (2008) Lin Xia et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started